Alteration of cartilage metabolism by cells from osteoarthritic bone

被引:164
作者
Westacott, CI [1 ]
Webb, GR [1 ]
Warnock, MG [1 ]
Sims, JV [1 ]
Elson, CJ [1 ]
机构
[1] UNIV NEWCASTLE UPON TYNE,NEWCASTLE TYNE NE1 7RU,TYNE & WEAR,ENGLAND
来源
ARTHRITIS AND RHEUMATISM | 1997年 / 40卷 / 07期
关键词
D O I
10.1002/art.1780400713
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To determine whether bone cells alter cartilage metabolism. Methods. Bone cell cultures were established using explants obtained from the hip and knee joints of 9 patients with osteoarthritis (OA) and 6 subjects without arthritis (nonarthritic [NA]). NA human cartilage biopsy samples were incubated in the presence or absence of bone-derived cells, and the effects on glycosaminoglycan (GAG) release from cartilage were measured. Results. Bone cell cultures secreted osteocalcin (OC) and did not contain cells expressing leukocyte common antigen. None of the 8 cultures established from NA bone, compared with 17 of 32 from OA bone, significantly altered GAG release from cartilage (P = 0.006). In knees with medial joint damage, 38% of the cultures derived from the medial side of the joint increased GAG release from cartilage. In contrast, 77% of the cultures derived from the lateral side of the joint had an effect on GAG, with 38% increasing and 38% decreasing GAG release. Seven cytokines were measured in OA bone cell supernatants. No significant difference was apparent in the concentration of any one cytokine when supernatants were compared according to their effects on GAG release. Conclusion. Bone cells from OA patients can influence cartilage metabolism. This might explain why increased subchondral bone activity can predict cartilage loss.
引用
收藏
页码:1282 / 1291
页数:10
相关论文
共 33 条
[1]   PRODUCTION OF OSTEOCALCIN BY HUMAN-BONE CELLS-INVITRO - EFFECTS OF 1,25(OH)2D3, 24,25(OH)2D3, PARATHYROID-HORMONE, AND GLUCOCORTICOIDS [J].
BERESFORD, JN ;
GALLAGHER, JA ;
POSER, JW ;
RUSSELL, RGG .
METABOLIC BONE DISEASE & RELATED RESEARCH, 1984, 5 (05) :229-234
[2]  
Beresford JN, 1983, CLIN SCI, V64, P38
[3]  
BERESFORD JN, 1983, CALCIFIED TISSUE INT, V35, pA637
[4]   FIBROBLAST GROWTH-FACTOR INCREASES TNF-ALPHA-MEDIATED PROSTAGLANDIN-E(2) PRODUCTION AND TNF-ALPHA RECEPTOR EXPRESSION IN HUMAN FIBROBLASTS [J].
CANDELA, M ;
BARKER, SC ;
BALLOU, LR .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 1993, 120 (01) :43-50
[5]  
CARTER DR, 1987, CLIN ORTHOP RELAT R, V219, P237
[6]   INDUCTION OF INTERLEUKIN-1 RECEPTORS ON CHONDROCYTES BY FIBROBLAST GROWTH-FACTOR - A POSSIBLE MECHANISM FOR MODULATION OF INTERLEUKIN-1 ACTIVITY [J].
CHANDRASEKHAR, S ;
HARVEY, AK .
JOURNAL OF CELLULAR PHYSIOLOGY, 1989, 138 (02) :236-246
[7]   EVIDENCE FOR METALLOPROTEINASE AND METALLOPROTEINASE INHIBITOR IMBALANCE IN HUMAN OSTEOARTHRITIC CARTILAGE [J].
DEAN, DD ;
MARTELPELLETIER, J ;
PELLETIER, JP ;
HOWELL, DS ;
WOESSNER, JF .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (02) :678-685
[8]   PREDICTION OF THE PROGRESSION OF JOINT SPACE NARROWING IN OSTEOARTHRITIS OF THE KNEE BY BONE-SCINTIGRAPHY [J].
DIEPPE, P ;
CUSHNAGHAN, J ;
YOUNG, P ;
KIRWAN, J .
ANNALS OF THE RHEUMATIC DISEASES, 1993, 52 (08) :557-563
[9]   IMPROVED QUANTITATION AND DISCRIMINATION OF SULFATED GLYCOSAMINOGLYCANS BY USE OF DIMETHYLMETHYLENE BLUE [J].
FARNDALE, RW ;
BUTTLE, DJ ;
BARRETT, AJ .
BIOCHIMICA ET BIOPHYSICA ACTA, 1986, 883 (02) :173-177
[10]  
HUGHES SS, 1995, J BONE MINER RES, V10, P533